Cargando…

Negative Impact of Skeletal Muscle Loss after Systemic Chemotherapy in Patients with Unresectable Colorectal Cancer

BACKGROUND: Skeletal muscle depletion (sarcopenia) is closely associated with limited physical ability and high mortality. This study evaluated the prognostic significance of skeletal muscle status before and after chemotherapy in patients with unresectable colorectal cancer (CRC). METHODS: We condu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miyamoto, Yuji, Baba, Yoshifumi, Sakamoto, Yasuo, Ohuchi, Mayuko, Tokunaga, Ryuma, Kurashige, Junji, Hiyoshi, Yukiharu, Iwagami, Shiro, Yoshida, Naoya, Watanabe, Masayuki, Baba, Hideo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4466562/ https://www.ncbi.nlm.nih.gov/pubmed/26069972 http://dx.doi.org/10.1371/journal.pone.0129742

Ejemplares similares

Preoperative skeletal muscle status is associated with tumor‐infiltrating lymphocytes and prognosis in patients with colorectal cancer
por: Daitoku, Nobuya, et al.
Publicado: (2022)

Activin A promotes cell proliferation, invasion and migration and predicts poor prognosis in patients with colorectal cancer
por: Daitoku, Nobuya, et al.
Publicado: (2022)

Laparoscopic surgery for colorectal cancer with persistent descending mesocolon
por: Hiyoshi, Yukiharu, et al.
Publicado: (2019)

Precision medicine for adjuvant chemotherapy of resected colorectal cancer
por: Miyamoto, Yuji, et al.
Publicado: (2020)

The advanced lung cancer inflammation index is a novel independent prognosticator in colorectal cancer patients after curative resection
por: Horino, Taichi, et al.
Publicado: (2021)

Cancer-related multiple brain infarctions caused by Trousseau syndrome in a patient with metastatic colon cancer: a case report
por: Akiyama, Takahiko, et al.
Publicado: (2016)

Prognostic and clinical impact of PIK3CA mutation in gastric cancer: pyrosequencing technology and literature review
por: Harada, Kazuto, et al.
Publicado: (2016)

Port site recurrence of esophageal adenocarcinoma after minimally invasive esophagectomy: a case report
por: Horino, Taichi, et al.
Publicado: (2020)

Emerging evidence of immunotherapy for colorectal cancer
por: Miyamoto, Yuji, et al.
Publicado: (2022)

Ongoing 5-year+ survival after multiple metastasectomies, followed by CAPOX plus bevacizumab, for metastatic colorectal cancer
por: Matsuishi, Kozue, et al.
Publicado: (2020)

Indoleamine 2, 3‐dioxygenase 1 promoter hypomethylation is associated with poor prognosis in patients with esophageal cancer
por: Kiyozumi, Yuki, et al.
Publicado: (2019)

IgG4-related disease presenting as a submucosal tumor of the stomach resected with laparoscopic endoscopic cooperative surgery: a case report
por: Yamane, Taishi, et al.
Publicado: (2020)

Synchronous NET and colorectal cancer development: a case report
por: Yumoto, Shinsei, et al.
Publicado: (2020)

Lysyl oxidase impacts disease outcomes and correlates with global DNA hypomethylation in esophageal cancer
por: Kalikawe, Rebecca, et al.
Publicado: (2019)

Early gastric cancer metastasizing to the rectum, possibly via a hematogenous route: a case report and review of literature
por: Uemura, Norio, et al.
Publicado: (2016)

Thyroid metastasis from esophageal adenocarcinoma: a case report and literature review
por: Yumoto, Shinsei, et al.
Publicado: (2019)

Multiple heterochronic gastrointestinal stromal tumors in the stomach detected 6 years after resection: a case report
por: Yasuda, Tadahito, et al.
Publicado: (2020)

TET family proteins and 5-hydroxymethylcytosine in esophageal squamous cell carcinoma
por: Murata, Asuka, et al.
Publicado: (2015)

Multiple skeletal muscle metastases from poorly differentiated gastric adenocarcinoma
por: Koga, Yuki, et al.
Publicado: (2015)

Presacral lymph node recurrence of rectal intramucosal adenocarcinoma after endoscopic mucosal resection: a case report
por: Horino, Taichi, et al.
Publicado: (2020)

Trastuzumab upregulates programmed death ligand-1 expression through interaction with NK cells in gastric cancer
por: Yamashita, Kohei, et al.
Publicado: (2020)

Adapted systemic inflammation score as a novel prognostic marker for esophageal squamous cell carcinoma patients
por: Nomoto, Daichi, et al.
Publicado: (2021)

Prognostic and clinical impact of PD-L2 and PD-L1 expression in a cohort of 437 oesophageal cancers
por: Okadome, Kazuo, et al.
Publicado: (2020)

Can PD-L1 expression evaluated by biopsy sample accurately reflect its expression in the whole tumour in gastric cancer?
por: Yamashita, Kohei, et al.
Publicado: (2019)

Primary colonic well-differentiated / dedifferentiated liposarcoma of the ascending colon: a case report
por: Sawayama, Hiroshi, et al.
Publicado: (2017)

Glucose transporter 1 regulates the proliferation and cisplatin sensitivity of esophageal cancer
por: Sawayama, Hiroshi, et al.
Publicado: (2019)

Relationship between Fusobacterium nucleatum and antitumor immunity in colorectal cancer liver metastasis
por: Sakamoto, Yuki, et al.
Publicado: (2021)

UHRF1 regulates global DNA hypomethylation and is associated with poor prognosis in esophageal squamous cell carcinoma
por: Nakamura, Kenichi, et al.
Publicado: (2016)

Small bowel perforation due to indistinguishable metastasis of angiosarcoma: case report and brief literature review
por: Uchihara, Tomoyuki, et al.
Publicado: (2016)

A case of clinical stage I gastric cancer with a schwannoma on the left supraclavicular fossa suspected as Virchow’s node metastasis
por: Hara, Yoshihiro, et al.
Publicado: (2022)

Evaluation of clinical outcomes with propensity‐score matching for colorectal cancer presenting as an oncologic emergency
por: Ogawa, Katsuhiro, et al.
Publicado: (2022)

Immune-related adverse events and prognosis in patients with upper gastrointestinal cancer treated with nivolumab
por: Hara, Yoshihiro, et al.
Publicado: (2022)

Preoperative transferrin level is a novel prognostic marker for colorectal cancer
por: Sawayama, Hiroshi, et al.
Publicado: (2021)

KRAS and BRAF Mutations in 203 Esophageal Squamous Cell Carcinomas: Pyrosequencing Technology and Literature Review
por: Shigaki, Hironobu, et al.
Publicado: (2012)

Fibroblast growth factor receptor 2 expression, but not its genetic amplification, is associated with tumor growth and worse survival in esophagogastric junction adenocarcinoma
por: Tokunaga, Ryuma, et al.
Publicado: (2016)

Overall survival after recurrence in stage I–III colorectal cancer patients in accordance with the recurrence organ site and pattern
por: Sawayama, Hiroshi, et al.
Publicado: (2021)

Carbohydrate antigen 19-9 is a useful prognostic marker in esophagogastric junction adenocarcinoma
por: Tokunaga, Ryuma, et al.
Publicado: (2015)

Irinotecan Plus S-1 Followed by Hepatectomy for a Patient with Initially Unresectable Colorectal Liver Metastases, Who Showed Severe Drug Rash with Oxaliplatin Plus 5-FU and Leucovorin (FOLFOX)
por: Komori, Hiroyuki, et al.
Publicado: (2014)

Fusobacterium nucleatum in gastroenterological cancer: Evaluation of measurement methods using quantitative polymerase chain reaction and a literature review
por: Yamamura, Kensuke, et al.
Publicado: (2017)

Co-occurrence of liver metastasis of gastrointestinal stromal tumor and hepatocellular carcinoma: a case report
por: Yamashita, Kohei, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_elt11pmkoh6isavlj87tus008k